4//SEC Filing
Birchall Jonathan 4
Accession 0001169245-21-000112
CIK 0001169245other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 8:46 PM ET
Size
5.8 KB
Accession
0001169245-21-000112
Insider Transaction Report
Form 4
Birchall Jonathan
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-11-08$3.37/sh+250,000$842,500→ 250,000 totalExercise: $3.37Exp: 2031-11-08→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on November 8, 2022, the first anniversary of the Vesting Commencement Date, and the remainder of the shares subject to the option shall vest in equal monthly installments over 36 months on the same day of the month as the Vesting Commencement Date, subject to the reporting person's continued service through each such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001892776
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 8:46 PM ET
- Size
- 5.8 KB